Cirrhotic COVID-19 survivors show poor short-term outcomes, no differences long-term

SAN DIEGO — Patients with cirrhosis who survived COVID-19 may not have worsening of underlying disease or death in the long-term compared with cirrhotic patients who never acquired COVID-19, noted data from Digestive Disease Week 2022.“While previous studies have focused on the clinical outcomes of COVID-19 disease in patients with cirrhosis, there has been a scarcity of data about the impact of an episode of COVID-19 on the course of underlying liver disease in cirrhotics,” Monica Chowdhry, MD, gastroenterology fellow from West Virginia University, Morgantown, told Healio.Read More

Related Articles